What should I do if my platelet count drops instead of rising after taking avatrombopag?

The situation where platelets do not rise but fall after taking avatrombopag may involve multiple reasons. root

Avatrombopag is indicated for the treatment of thrombocytopenia associated with chronic liver disease (CLD) in adults, particularly before elective diagnostic procedures or surgery. It promotes platelet proliferation, differentiation, maturation and division by simulating the biological effects of thrombopoietin, thereby increasing platelet count. However, it takes about a week from megakaryocyte formation to platelet production.

Studies have shown that avatrombopag has a lower response rate in patients with low baseline platelets (eg, 10 to 20×10^9/L). Therefore, in such patients, other platelet-raising drugs, such as recombinant human thrombopoietin, or aggressive platelet transfusion may need to be considered.

Make sure the patient takes the medication correctly as directed, at the appropriate dose, and with food to increase absorption. At the same time, medication should be used for a sufficient course of treatment to avoid disease recurrence or platelet decline due to insufficient treatment.

After taking avatrombopag, an increase in platelet count is usually observed within 3 to 5 days, with a peak occurring between 10 and 13 days. Therefore, if the reexamination is too early, a significant increase in platelet count may not be seen. It is recommended to conduct a reexamination from 10 to 13 days after taking the medication to evaluate the efficacy.

If the platelet count is still low after all the above factors have been eliminated, other potential causes may need to be considered, such as drug expiration, the effects of other drugs, disease aggravation, etc. In this case, it is recommended to go to the hospital to find out the specific cause and carry out targeted treatment.